bioRxiv Science⌕ Search

bioRxiv · 10.1101/2025.11.11.687823

Sleep arousals are associated with the polygenic risk for developing Alzheimer's disease and with cognitive decline in healthy late middle-aged individuals

Abstract

ObjectiveSleep disturbances are increasingly recognized as early features of Alzheimers disease (AD) neuropathology. In that context, spontaneous arousals during sleep have been associated with the burden of Amyloid beta in the brain of healthy late middle-aged individuals. Whether the heterogeneity of arousals during sleep may be related to the genetic risk of developing AD in young adults is not established. Likewise, whether arousals may be associated with cognitive decline is not known. Here, we evaluated the association between arousals, the genetic risk for developing AD and cognitive performance and cognitive decline in healthy young and late-middle-aged individuals. MethodsWe classified spontaneous arousals using in-lab EEG recordings of sleep in 453 younger individuals (22+/-2.7y; 49 women) and 87 late middle-aged individuals (59.3+/-5.3y; 59 women) based on their association with sleep stage transitions and changes in muscle tone. We examined the associations between arousal types and the polygenic risk scores (PRS) for AD, cognitive performance at baseline and, in late middle-aged individuals, cognitive decline over 2 and 7 years. ResultsThe prevalence of arousals associated with sleep stage transition was higher in late middle-aged vs. younger individuals. Among these arousals, those with and without muscle tone increases were, respectively, associated with lower and higher PRS for AD in late middle-aged but not in younger individuals. In the late middle-aged individuals, transition arousals associated with and without muscle tone increases were, respectively, correlated with better and worse attentional performance at baseline, and lower and larger memory decline over 2 or 7 years. ConclusionThe heterogeneity in spontaneous arousals during sleep may reflect their physiological intensity or underlying neural activation, and may indicate vulnerability to AD in late middle-aged individuals. The findings may contribute to identifying early markers of neurodegenerative risk. Statement of SignificanceSleep arousals are typically regarded as disruptive events, yet their physiological diversity may reveal important insights into brain health. In this study, we report that distinct subtypes of spontaneous sleep arousals are differentially associated with genetic vulnerability to Alzheimers disease (AD) and with future cognitive decline in healthy late middle-aged adults. Specifically, sleep arousals linked to sleep stage transitions but lacking muscle activation were related to higher polygenic risk for AD and greater memory decline, while those accompanied by muscle tone increases showed the opposite pattern. These findings indicate that subtle variations in sleep microstructure can reflect neurobiological vulnerability to AD before clinical symptoms emerge. By identifying electrophysiological markers associated with genetic risk and cognitive trajectories, this work advances the potential for using sleep-based biomarkers to detect and monitor preclinical neurodegenerative processes.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Mortazavi, N., Zubkov, M., Chylinski, D., Collette, F., Bastin, C., Maquet, P., Vandewalle, G., Talwar, P.. 2025-11-13. Sleep arousals are associated with the polygenic risk for developing Alzheimer's disease and with cognitive decline in healthy late middle-aged individuals. https://doi.org/10.1101/2025.11.11.687823

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Different hippocampal subfield volumes predict source memory performance and general cognitive ability in an adult lifespan sample

Modest positive associations between episodic memory performance and whole hippocampal and hippocampal subfield volumes have been reported in numerous prior studies. A smaller number of studies have reported associations between hippocampal volume and performance on tests of non-mnemonic cognition. The present study examined whether these associations were evident in a lifespan sample of cognitively healthy adults. Of particular interest was whether any identified associations were sensitive to age, and whether associations between subfield volumes and mnemonic and non-mnemonic performance were subfield dependent. We acquired high-resolution T1- and T2-weighted structural images from 163 adults (18-87 years of age). Participants also undertook a comprehensive neuropsychological test battery and an in-scanner test of source memory. Principal components analysis was employed to reduce the neuropsychological test scores to 5 cognitive components. Two components reflected memory performance while the other three reflected different aspects of non-mnemonic cognition. Hippocampal subfields (Cornu Ammonis (CA)1, CA2-3, dentate gyrus (DG) and subiculum) were segmented and measured with the Automated Segmentation of Hippocampus Subfields (ASHS) package. Source memory performance was selectively associated across participants with CA2-3 volume. By contrast, both mnemonic and non-mnemonic component scores derived from the test battery were associated exclusively with the volume of the DG. All associations were age-invariant. The findings indicate that different cognitive domains can be dissociated by virtue of their associations with different hippocampal subfields. Of importance, these associations appear to be life-long and hence are unlikely to reflect individual differences in age-related decline in structural integrity.

neuroscience↗

Cell type specific astrocytic feedback regulates excitation inhibition balance and cortical network dynamics

Astrocytes actively regulate synaptic transmission and neuronal excitability, yet their role in orchestrating macroscopic cortical network regimes and slow-wave oscillations remains an active area of reasearch. This study investigates how bidirectional neuron astrocyte interactions shape emergent population dynamics using a computational network model of excitatory and inhibitory neurons coupled to an astrocyte. The results identify astrocytic feedback topology, rather than astrocytic coupling strength alone, as a key determinant of emergent cortical network dynamics. By systematically dissecting pathway-specific connectivity, it has been shown that the neuronal population driving astrocytic activation and the neuronal population receiving gliotransmission jointly determine whether the network occupies asynchronous irregular (AI), synchronous irregular (SI), synchronous regular(SR), asynchronous regular(AR) or quiescent regimes.Directing gliotransmission selectively onto excitatory neurons consistently promotes population synchrony regardless of the population influencing astrocytic dynamics, whereas selective modulation of inhibitory interneurons induces network quiescence via strong suppression. Under dual-target gliotransmission, network synchrony is dictated by the population driving astrocytic dynamics: excitatory-only drive promotes synchrony, while combined or inhibitory-specific drive preserves asynchronous states. Furthermore, the model reveals that astrocytic signaling kinetics provide an additional temporal control mechanism that regulates the frequency and persistence of self sustained up states.

neuroscience↗

VCP inhibition prevents cone photoreceptor degeneration in the cpfl1 mouse model of achromatopsia

Achromatopsia (ACHM) is a rare autosomal recessive retinal disorder characterized by absent cone photoreceptor function from early life, leading to severe visual impairment. Mutations in genes involved in the cone phototransduction cascade frequently result in elevated cyclic guanosine monophosphate (cGMP) levels and activation of stress pathways, including endoplasmic reticulum (ER) stress and the unfolded protein response. Targeting common downstream mechanisms rather than individual mutations may provide a broadly applicable therapeutic strategy. Here, we investigated whether pharmacological inhibition of valosin-containing protein (VCP), a key regulator of ER and protein homeostasis, can prevent cone degeneration in the spontaneous cone photoreceptor function loss 1 (cpfl1) mouse model of ACHM. Organotypic culture of retinal explants from cpfl1 mice were treated with the selective VCP inhibitor ML240. Cone survival, cell death, opsin expression and localization were assessed by TUNEL assay, immunohistochemistry, and quantitative image analysis. ML240 treatment significantly increased cone density and improved cone opsin expression and trafficking to the outer segments (OSs) in cpfl1 explants compared to controls. Importantly, rhodopsin trafficking in rod photoreceptors was unaffected, indicating that VCP inhibition did not impair normal rod phototransduction. These findings demonstrate that VCP inhibition by ML240 effectively preserves cone photoreceptors and improves cone-specific functional markers in the cpfl1 model. Targeting VCP may represent a mutation-independent therapeutic strategy for preventing cone death in ACHM.

neuroscience↗